Oramed Pharmaceuticals
ORMP
#9002
Rank
C$0.18 B
Marketcap
C$4.53
Share price
6.51%
Change (1 day)
30.46%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): C$1.13

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$1.12. In 2024 the company made an earnings per share (EPS) of C-$0.67 a decrease over its 2023 EPS that were of C$0.19.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$1.13-269.42%
2024C-$0.67-442.86%
2023C$0.19-114.89%
2022C-$1.3020.51%
2021C-$1.0839.29%
2020C-$0.78-31.71%
2019C-$1.14-4.65%
2018C-$1.198.86%
2017C-$1.10-9.2%
2016C-$1.2129.85%
2015C-$0.938.06%
2014C-$0.865.08%
2013C-$0.823.51%
2012C-$0.79137.5%
2011C-$0.33-60%
2010C-$0.83-0%
2009C-$0.83-16.67%
2008C-$1.00-25%
2007C-$1.33700%
2006C-$0.17303.56%
2005C-$0.04124

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
C-$8.24-833.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
C$4.87 333.76%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
C$5.14 357.49%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
C-$0.42-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
C-$0.26-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA